Skip to main content
STADA Arzneimittel AG logo

STADA Arzneimittel AG — Investor Relations & Filings

Ticker · SAZ ISIN · DE0007251803 LEI · 529900FMTTLMH0P0DL10 HM Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2013-09-09 Regulatory Filings
Country DE Germany
Listing HM SAZ

About STADA Arzneimittel AG

https://www.stada.com/

STADA Arzneimittel AG is a pharmaceutical company that operates on a three-pillar strategy consisting of generics, consumer healthcare products, and specialty pharmaceuticals. The company is a leading manufacturer of affordable generic medicines, which have been a core part of its business since its founding. In the consumer healthcare segment, STADA markets a wide portfolio of over-the-counter (OTC) products and well-known brands. The specialty pharmaceuticals division focuses on developing and marketing value-added medicines, including an expanding portfolio of biosimilars for therapeutic areas such as oncology, immunology, and bone health.

Recent filings

Filing Released Lang Actions
Foregoing the use of external consultants brings millions in savings: STADA establishes IT shared service center for the Group
Regulatory Filings Classification · 100% confidence The document is titled 'Press release' and announces a corporate action: establishing an internal IT shared service center to save costs by foregoing external consultants. It includes key financial figures related to expected savings (millions of euros) and provides context about the company (STADA Arzneimittel AG) and the date (September 9, 2013). This type of announcement, detailing operational restructuring and its financial impact, is typically disseminated as a general corporate news release. Since it is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific capital/dividend announcement, and it is a direct news announcement about internal strategy/operations, the most appropriate classification is Regulatory Filings (RNS) as a general corporate announcement, or potentially a miscellaneous corporate news item. Given the options, RNS serves as the best general corporate news/announcement fallback when specific categories like ER or CAP do not apply. It is not a Call Transcript (CT), Investor Presentation (IP), or a formal report (AR, IR, 10-K).
2013-09-09 English
Declaration of Voting Results & Voting Rights Announcements 2013
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly states that Morgan Stanley informed the company that its Voting Rights on STADA Arzneimittel AG have fallen below a specific threshold, referencing Article 21, Section 1 of the WpHG (German Securities Trading Act). This content directly relates to the declaration of voting rights changes or announcements concerning shareholder votes. This aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length is short (1458 chars), but the content is the announcement itself, not a notice about another report, making DVA the most specific fit over the general RNS.
2013-09-06 English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights Announcement' and explicitly states the total number of Voting Rights as of the end of August 2013, referencing Article 26a of the WpHG (German Securities Trading Act). This type of announcement, detailing the total number of shares/voting rights outstanding, is a specific regulatory disclosure. Among the provided codes, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most appropriate fit for an official announcement regarding the total voting rights count, even if it is not the result of a specific vote, as it pertains directly to the structure underpinning shareholder voting power.
2013-08-30 English
STADA purchases British OTC manufacturer Thornton & Ross
M&A Activity Classification · 99% confidence The document is an 'Ad-hoc-update' dated August 16, 2013, announcing that STADA Arzneimittel AG has signed a contract to purchase Thornton & Ross. This is a significant corporate transaction involving acquisition/merger activity. Based on the provided definitions, the most appropriate category for an announcement related to a merger proposal or takeover bid is 'M&A Activity' (Code: TAR). Although it is an ad-hoc announcement, the core subject matter is M&A, which is more specific than the general 'RNS' fallback.
2013-08-16 English
Q2 Report 2013
Interim / Quarterly Report Classification · 100% confidence The document is a 'Consolidated Interim Management Report' for the STADA Group, covering the first half of 2013 (Jan 1–June 30). It contains detailed financial tables, key performance indicators (EBITDA, EBIT, Net Income), and a management discussion and analysis of the financial results. Since it provides comprehensive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2013
2013-08-13 English
STADA with dynamic sales growth in the first half of 2013
Earnings Release Classification · 100% confidence The document explicitly details financial performance metrics (sales, EBITDA, net income) for the 'first half of 2013' (1-6/2013) compared to the previous year, including key figures and management commentary on results and outlook. This content structure is characteristic of a periodic financial report covering a period shorter than a full year. The presence of 'Half Year Results' in the keywords section further confirms this. Therefore, it aligns best with the Interim / Quarterly Report definition (IR). It is not a full Annual Report (10-K), nor is it just a brief Earnings Release (ER) as it contains substantial detail on segments and regions. H1 2013
2013-08-08 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.